Patent details

EP2343320 Title: ANTI-GITR ANTIBODIES AND USES THEREOF

Basic Information

Publication number:
EP2343320
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP101816387
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTI-GITR ANTIBODIES AND USES THEREOF
French Title of Invention:
ANTICORPS CONTRE GITR ET LEUR UTILISATIONS
German Title of Invention:
ANTI-GITR ANTIKÖRPER UND IHRE VERWENDUNG
SPC Number:

Dates

Filing date:
27/03/2006
Grant date:
25/10/2017
EP Publication Date:
13/07/2011
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/10/2017
EP B1 Publication Date:
25/10/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
27/03/2018
Expiration date:
27/03/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/10/2017
 
 

Name:
GITR, Inc.
Address:
55 Cambridge Parkway, Suite 102, Cambridge, MA 02142, United States (US)

Inventor

1

Name:
Szymanska, Grazyna
Address:
United States (US)

2

Name:
Ponath, Paul
Address:
United States (US)

3

Name:
Ponte, Jose F.
Address:
United States (US)

4

Name:
Rosenzweig, Michael
Address:
United States (US)

5

Name:
Smith, L. Mary
Address:
United States (US)

Priority

1

Priority Number:
665322 P
Priority Date:
25/03/2005
Priority Country:
United States (US)

2

Priority Number:
687265 P
Priority Date:
03/06/2005
Priority Country:
United States (US)

Classification

IPC classification:
A61K 39/395; A61P 31/00; A61P 35/00; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
201743
Publication date:
25/10/2017
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages
31/07/2018 Outgoing Correspondence 1